{"schema_version":"alpha-profile-public-v1","slug":"elisabeth-sandoval-little","canonical_url":"https://registry.alpha.ac/people/elisabeth-sandoval-little","as_of":"2026-10-18T05:41:42.65394+00:00","published_at":"2026-09-02T02:37:23.806409+00:00","last_reviewed_at":"2026-05-16T10:02:52.99+00:00","identity":{"display_name":"Elisabeth Sandoval Little","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"VYNE Therapeutics Inc.","company_slug":"vyne-therapeutics-inc","exchange":"NASDAQ","ticker":"VYNE","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","effective_date":"2025-11-12","last_checked_at":"2026-04-25T01:04:02.567+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=elisabeth-sandoval-little","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=elisabeth-sandoval-little&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Currently serves as a consultant to the pharmaceutical industry. Served as Chief Commercial Officer and Executive Vice President of Corporate Strategy for Alder Biopharmaceuticals from 2016 to 2019. Previously Chief Commercial Officer for KYTHERA Biopharmaceuticals from 2012 to 2015 until its acquisition by Allergan."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"VYNE Therapeutics Inc.","organizationId":"vyne-therapeutics-inc","title":"Director","period":"2019-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"VYNE Therapeutics Inc.","company_slug":"vyne-therapeutics-inc","exchange":"NASDAQ","ticker":"VYNE","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2019-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","effective_date":"2025-11-12","last_checked_at":"2026-04-25T01:04:02.567+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:21:40.897464+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","published_at":"2025-11-12T00:00:00+00:00","last_checked_at":"2026-05-16T03:21:40.761194+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.187345+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Elisabeth Sandoval Little currently serves as Director at VYNE Therapeutics Inc..","claim_state":"verified","valid_from":"2025-11-12","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:21:40.85103+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","published_at":"2025-11-12T00:00:00+00:00","last_checked_at":"2026-05-16T03:21:40.761194+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Elisabeth Sandoval Little serves on Audit, Compensation.","claim_state":"verified","valid_from":"2025-11-12","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:21:40.876441+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","published_at":"2025-11-12T00:00:00+00:00","last_checked_at":"2026-05-16T03:21:40.761194+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:21:40.939117+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","published_at":"2025-11-12T00:00:00+00:00","last_checked_at":"2026-05-16T03:21:40.761194+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.219236+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"VYNE Therapeutics Inc.","claim_text":"Elisabeth Sandoval Little is associated with VYNE Therapeutics Inc..","claim_state":"verified","valid_from":"2026-02-27","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.172364+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"Elisabeth Sandoval Little is listed as Director at VYNE Therapeutics Inc..","claim_state":"verified","valid_from":"2026-02-27","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.152014+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Board of Directors","company":"PROCEPT BioRobotics Corporation"},"claim_text":"Elisabeth Sandoval Little is also linked to PROCEPT BioRobotics Corporation as Board of Directors.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.249697+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T03:21:40.91839+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","published_at":"2025-11-12T00:00:00+00:00","last_checked_at":"2026-05-16T03:21:40.761194+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Elisabeth Sandoval Little as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T10:02:53.20382+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"VYNE 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","published_at":"2026-02-27T00:00:00+00:00","last_checked_at":"2026-05-16T10:02:53.052236+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:elisabeth-sandoval-little","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2019-01-01 · current","organization":"VYNE Therapeutics Inc.","organization_id":"vyne-therapeutics-inc"},"claim_text":"Director at VYNE Therapeutics Inc. (2019-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/elisabeth-sandoval-little#profile","url":"https://registry.alpha.ac/people/elisabeth-sandoval-little","dateModified":"2026-05-16T10:02:52.99+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/elisabeth-sandoval-little#person","name":"Elisabeth Sandoval Little","url":"https://registry.alpha.ac/people/elisabeth-sandoval-little","jobTitle":"Director","worksFor":{"@type":"Organization","name":"VYNE Therapeutics Inc.","tickerSymbol":"NASDAQ: VYNE"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","memberOf":{"@type":"Organization","name":"VYNE Therapeutics Inc.","url":"https://registry.alpha.ac/companies/vyne-therapeutics-inc","tickerSymbol":"NASDAQ: VYNE"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465925110346/tm2530678-1_def14a.htm","name":"VYNE DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1566044/000156604426000002/vyne-20251231.htm","name":"VYNE 10-K executive officers"}],"mainEntityOfPage":"https://registry.alpha.ac/people/elisabeth-sandoval-little"},"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"d751713988987e9331980363e24189ce","subject":"alpha:person:elisabeth-sandoval-little","as_of":"2026-10-18T05:41:42.984066+00:00","recorded_at":"2026-10-18T05:41:42.984066+00:00","availability":"available","records":[],"next_offset":null,"limitations":["Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage."]},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":7,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":7,"corroborated":3,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":3,"sources":4,"distinct_sources":2,"role_claims":1,"last_reviewed_at":"2026-05-16T10:02:52.99+00:00","observed_at":"2026-10-18T05:41:42.65394+00:00","freshness_days":155}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"elisabeth-sandoval-little","canonical_url":"https://registry.alpha.ac/people/elisabeth-sandoval-little"},"publication":{"published_at":"2026-09-02T02:37:23.806409+00:00","last_reviewed_at":"2026-05-16T10:02:52.99+00:00","as_of":"2026-10-18T05:41:42.65394+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/elisabeth-sandoval-little","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/elisabeth-sandoval-little","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/elisabeth-sandoval-little.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}